| Application no. and date | 21752123.6 (espacenet) (Federated) (European Patent Register), 20210729 | | Patent/reg. no. and date | DK/EP 4118200, 20251008 | | Publication date | 20230118 | | Priority no. and date | GB 202011813, 20200729, GB 202100648, 20210118, GB 202105924, 20210426 | | EP pub. no. and date |
EP 4118200 20230118 | | Effective date | | | Applicant/owner | Spur Therapeutics Limited, Sycamore House
Gunnels Wood Road
Stevenage, Hertfordshire SG1 2BP, GB | | Applicant ref. no. | BB371850EPDK | | Inventor | COMPER, Fabrizio,
Stevenage, Hertfordshire SG1 2BP, GB,
NATHWANI, Amit,
Stevenage, Hertfordshire SG1 2BP, GB,
MCINTOSH, Jenny,
Stevenage, Hertfordshire SG1 2BP, GB,
CORBAU, Romuald,
Stevenage, Hertfordshire SG1 2BP, GB,
KIA, Azadeh,
Stevenage, Hertfordshire SG1 2BP, GB,
MIRANDA, Carlos,
Stevenage, Hertfordshire SG1 2BP, GB | | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | | Opponent | | | IPC Class | A61K 38/00 (2006.01) , A61K 38/47 (2006.01) , C12N 9/24 (2006.01) | | Title | MUTERET BETA-GLUCOCEREBROSIDASE MED FORBEDRET STABILITET | | Int. application no. | GB2021051969 | | Int. publication no. | WO2022023761 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
